首页> 美国卫生研究院文献>Oncotarget >Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection
【2h】

Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection

机译:与新辅助化疗及手术切除治疗的局部晚期胃癌患者相关的预后因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this retrospective study, we analyzed prognostic factors associated with survival outcomes in 73 locally advanced gastric cancer patients treated with neoadjuvant chemotherapy (NAC) followed by surgical resection. Median disease-free survival (DFS) for 64 patients that received R0 resection was 685 days, whereas median overall survival (OS) for 73 patients was 930 days. Multivariate analysis demonstrated that post-treatment nodal stages (P = 0.002), nervous invasion (P = 0.0492) and serum CA199 levels (P = 0.0398) were independent prognostic factors for DFS. Nodal stages (P = 0.0007), presence of nervous invasion (P = 0.0259) and non-radical resection (P = 0.0165) were independent prognostic factors for OS. These results indicate that post-treatment nodal stages, neural invasion and serum CA199 levels are all associated with poor DFS. Moreover, post-treatment nodal stage, resection type and neural invasion status are independent prognostic factors for OS.
机译:在这项回顾性研究中,我们分析了73例接受新辅助化疗(NAC)并随后手术切除的局部晚期胃癌患者的生存结局相关的预后因素。接受R0切除术的64例患者的中位无病生存(DFS)为685天,而73例患者的中位总体生存(OS)为930天。多因素分析表明,治疗后的淋巴结分期(P = 0.002),神经浸润(P = 0.0492)和血清CA199水平(P = 0.0398)是DFS的独立预后因素。淋巴结分期(P = 0.0007),是否存在神经浸润(P = 0.0259)和非根治性切除(P = 0.0165)是OS的独立预后因素。这些结果表明,治疗后的淋巴结分期,神经侵袭和血清CA199水平均与差的DFS有关。此外,治疗后的淋巴结分期,切除类型和神经侵犯状态是OS的独立预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号